Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.
Vision & Reality 9th EditionPatient Adherence: The Next Frontier in Patient CareMay 2011<br />
Vision & Reality is Capgemini Consulting’s 9th annual thought leadership publication for the Life Sciences industry<br />E...
Payers: 7
Pharmacists: 4
Others1: 6</li></ul>Geographic Representation<br /><ul><li>North America: 48
Europe: 18
Including: France, Denmark, Germany, Netherlands, Portugal, UK, Spain and Switzerland.
Additionally, secondary research was conducted by Capgemini’s Life Sciences Strategy Lab</li></ul>Note: (1) Others include...
What is patient adherence?<br />Adherence is defined as taking a treatment as prescribed (compliance) AND over the prescri...
Upcoming SlideShare
Loading in …5
×

Patient Adherence: The Next Frontier in Patient Care - Key findings from Capgemini’s latest Vision & Reality research

4,462 views

Published on

Lack of patient adherence to prescribed medications poses a tremendous challenge to the global healthcare community. Bridging the adherence gap is a ‘must do’ for pharmaceutical companies to protect their top line while transforming themselves from product to patient-centric organizations.

This is the result of a Capgemini Consulting research across Europe and the United States. The aim of the research was to understand the root causes of non-adherence, how the industry has addressed non-adherence in the past and what an innovative approach should look like.

http://www.capgemini.com/services-and-solutions/by-industry/life-sciences/vision-and-reality/

Published in: Business, Health & Medicine
  • Be the first to comment

Patient Adherence: The Next Frontier in Patient Care - Key findings from Capgemini’s latest Vision & Reality research

  1. 1. Vision & Reality 9th EditionPatient Adherence: The Next Frontier in Patient CareMay 2011<br />
  2. 2. Vision & Reality is Capgemini Consulting’s 9th annual thought leadership publication for the Life Sciences industry<br />Each year Capgemini Consulting <br />examines a topic critical to the life sciences industry…<br />This year we have focused on the issue of patients’ adherence to medication<br /><ul><li>We conducted 66 one-on-one interviews with Life Sciences executives</li></ul>Sector Representation<br /><ul><li>Pharmaceutical/Biotech companies: 49
  3. 3. Payers: 7
  4. 4. Pharmacists: 4
  5. 5. Others1: 6</li></ul>Geographic Representation<br /><ul><li>North America: 48
  6. 6. Europe: 18
  7. 7. Including: France, Denmark, Germany, Netherlands, Portugal, UK, Spain and Switzerland.
  8. 8. Additionally, secondary research was conducted by Capgemini’s Life Sciences Strategy Lab</li></ul>Note: (1) Others include Patient Advocacy Groups, Academic centres and a healthcare consulting group<br />Copyright © 2011 Capgemini Consulting. All rights reserved.<br />2<br />
  9. 9. What is patient adherence?<br />Adherence is defined as taking a treatment as prescribed (compliance) AND over the prescribed period of time (persistence)<br />Compliance<br />Adherence<br /><ul><li>Extent to which a patient follows a prescribed treatment
  10. 10. Extent to which a patient follows a prescribed treatment plan agreed on with the physician
  11. 11. Adherence implies a more collaborative relationship between patients and clinicians and is more respectful of the role of patients in their own treatment</li></ul>Persistence<br /><ul><li>Extent to which a patient consistently continues treatment over a period of time</li></ul>Source: (1) The Free Dictionary - http://medical-dictionary.thefreedictionary.com 2) Datamonitor: Disease Management and Drug Adherence, 06-2007<br />Copyright © 2011 Capgemini Consulting. All rights reserved.<br />3<br />
  12. 12. 9<br />Only about 50% of patients take medications as prescribed and there is a sharp drop in adherence over time on treatment<br />Adherence rates across the duration of therapy<br />Adherence rates of select <br />conditions in US, 20081<br />Adherence rates to prescribed medicines estimated by respondents2<br />Source: (1) Andree Bates, “Ensuring Profitable Patient Adherence Programs”, Eularis, March 2010 (2) Source: Capgemini external interviews - Q2) What in your opinion is the current level of adherence in patients?<br />Copyright © 2011 Capgemini Consulting. All rights reserved.<br />4<br />
  13. 13. We analyzed factors of non-adherence, influencers of patient behaviors, and interventions to improve adherence<br />Dimensions of <br />Patient Adherence<br />Source: Capgemini analysis<br />Copyright © 2011 Capgemini Consulting. All rights reserved.<br />5<br />
  14. 14. Across all respondent groups, patient attitude and therapy complexity were identified as main factors of non-adherence<br />Average rating of factors <br />driving adherence across <br />respondent groups<br />Q4) Could you please prioritize the most dominant factors and also identify the top 3 stakeholders who can influence these factors?<br />Source: Capgemini external interviews<br />Copyright © 2011 Capgemini Consulting. All rights reserved.<br />6<br />
  15. 15. But things are changing and focus on patient adherence improvement will increase<br />Healthcare Reforms<br />Healthcare Industry Involvement and Collaboration<br />Levers to Improve Adherence<br />Digital Health Media<br />Technology Advancements<br />Copyright © 2011 Capgemini Consulting. All rights reserved.<br />7<br />
  16. 16. Going forward, we recommend companies adopt a comprehensive and coherent framework to address patient adherence <br />Source: Capgemini analysis <br />Copyright © 2011 Capgemini Consulting. All rights reserved.<br />8<br />
  17. 17. http://www.capgemini.com/services-and-solutions/<br />by-industry/life-sciences/vision-and-reality/<br />

×